|12.35||-0.24 / -1.91%|
Data as of 3:59pm ET
|12.35||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 19.00, with a high estimate of 23.50 and a low estimate of 7.00. The median estimate represents a +53.85% increase from the last price of 12.35.
The current consensus among 3 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.